|Videos|June 15, 2022
Clinical Implications of the TIVO-3 Trial
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
4
Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions
5